1. Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer. (August 2017) Authors: Morisada, Megan; Moore, Ellen C.; Hodge, Rachel; Friedman, Jay; Cash, Harrison A.; Hodge, James W.; Mitchell, James B.; Allen, Clint T. Journal: Oral oncology Issue: Volume 71(2017) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. Issue 1 (21st June 2018) Authors: Friedman, Jay; Morisada, Megan; Sun, Lillian; Moore, Ellen C.; Padget, Michelle; Hodge, James W.; Schlom, Jeffrey; Gameiro, Sofia R.; Allen, Clint T. Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms. (3rd July 2018) Authors: Moore, Ellen C.; Sun, Lillian; Clavijo, Paul E.; Friedman, Jay; Harford, Joe B.; Saleh, Anthony D.; Van Waes, Carter; Chang, Esther H.; Allen, Clint T. Journal: Oncoimmunology Issue: Volume 7:Number 7(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗